image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 23.04
-8.26 %
$ 1.15 B
Market Cap
31.03
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 21, 2025.

The intrinsic value of one ASTH stock under the worst case scenario is HIDDEN Compared to the current market price of 23 USD, Astrana Health, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 21, 2025.

The intrinsic value of one ASTH stock under the base case scenario is HIDDEN Compared to the current market price of 23 USD, Astrana Health, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 21, 2025.

The intrinsic value of one ASTH stock under the best case scenario is HIDDEN Compared to the current market price of 23 USD, Astrana Health, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ASTH

image
$40.0$40.0$38.0$38.0$36.0$36.0$34.0$34.0$32.0$32.0$30.0$30.0$28.0$28.0$26.0$26.0$24.0$24.0$22.0$22.0Feb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '2515 Jul15 Jul
FINANCIALS
2.03 B REVENUE
46.72%
89.4 M OPERATING INCOME
5.60%
49.9 M NET INCOME
-13.69%
52.2 M OPERATING CASH FLOW
-23.49%
-192 M INVESTING CASH FLOW
-193.63%
135 M FINANCING CASH FLOW
3847.27%
620 M REVENUE
-6.74%
20.6 M OPERATING INCOME
2758.75%
6.22 M NET INCOME
189.50%
16.6 M OPERATING CASH FLOW
251.87%
0 INVESTING CASH FLOW
100.00%
0 FINANCING CASH FLOW
100.00%
Balance Sheet Astrana Health, Inc.
image
Current Assets 638 M
Cash & Short-Term Investments 291 M
Receivables 325 M
Other Current Assets 22.9 M
Non-Current Assets 716 M
Long-Term Investments 100 M
PP&E 46.9 M
Other Non-Current Assets 569 M
21.47 %23.97 %7.39 %3.46 %42.03 %Total Assets$1.4b
Current Liabilities 223 M
Accounts Payable 15.2 M
Short-Term Debt 15.3 M
Other Current Liabilities 192 M
Non-Current Liabilities 475 M
Long-Term Debt 457 M
Other Non-Current Liabilities 18.6 M
27.55 %65.43 %Total Liabilities$697.8m
EFFICIENCY
Earnings Waterfall Astrana Health, Inc.
image
Revenue 2.03 B
Cost Of Revenue 1.76 B
Gross Profit 271 M
Operating Expenses 182 M
Operating Income 89.4 M
Other Expenses 39.4 M
Net Income 49.9 M
3b3b2b2b2b2b1b1b500m500m002b(2b)271m(182m)89m(39m)50mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
13.34% GROSS MARGIN
13.34%
4.39% OPERATING MARGIN
4.39%
2.12% NET MARGIN
2.12%
6.05% ROE
6.05%
3.18% ROA
3.18%
4.81% ROIC
4.81%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Astrana Health, Inc.
image
60m60m50m50m40m40m30m30m20m20m10m10m00(10m)(10m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 49.9 M
Depreciation & Amortization 27.9 M
Capital Expenditures -8.03 M
Stock-Based Compensation 34.5 M
Change in Working Capital -63.6 M
Others -14.4 M
Free Cash Flow 44.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Astrana Health, Inc.
image
Wall Street analysts predict an average 1-year price target for ASTH of $55.8 , with forecasts ranging from a low of $36 to a high of $70 .
ASTH Lowest Price Target Wall Street Target
36 USD 56.25%
ASTH Average Price Target Wall Street Target
55.8 USD 141.97%
ASTH Highest Price Target Wall Street Target
70 USD 203.82%
Price
Max Price Target
Min Price Target
Average Price Target
70706565606055555050454540403535303025252020Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Astrana Health, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet The average of price targets set by Wall Street analysts indicates a potential upside of 97.3% in Astrana Health, Inc. (ASTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com - 1 week ago
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy Astrana Health, Inc. (ASTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com - 2 weeks ago
ASTH or CHE: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 2 weeks ago
Tap These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratio ASTH, KT, UPBD, NOAH and DXPE stand out with low EV-to-EBITDA ratios and strong 2025 earnings growth forecasts. zacks.com - 2 weeks ago
New Strong Buy Stocks for July 10th ASTH, LGCY, STM, BAYRY and KD have been added to the Zacks Rank #1 (Strong Buy) List on July 10, 2025. zacks.com - 2 weeks ago
Astrana Health Announces Closing of Prospect Health Acquisition ALHAMBRA, Calif. , July 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it closed the acquisition of Prospect Health on July 1st, 2025. prnewswire.com - 3 weeks ago
New Strong Sell Stocks for June 4th ASLE, ASTH and MITT have been added to the Zacks Rank #5 (Strong Sell) List on May 4 2025. zacks.com - 1 month ago
Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All ALHAMBRA, Calif. , June 3, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced several key additions to its senior leadership team. prnewswire.com - 1 month ago
Astrana Health, Inc. to Participate in Upcoming Investor Conference ALHAMBRA, Calif. , June 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO is participating in the William Blair 2025 Growth Stock Conference, being held in Chicago, from Tuesday, June 3, 2025 to Thursday June 5, 2025 including a presentation at 10:40 am CT on Wednesday, June 4. prnewswire.com - 1 month ago
Astrana Health, Inc. (ASTH) Q1 2025 Earnings Call Transcript Astrana Health, Inc. (NASDAQ:ASTH ) Q1 2025 Earnings Conference Call May 8, 2025 5:30 PM ET Company Participants Brandon Sim - President & Chief Executive Officer Chan Basho - Chief Operating & Financial Officer. Conference Call Participants Ryan Daniels - William Blair Michael Ha - Baird Jack Slevin - Jefferies Jailendra Singh - Truist Securities Ryan Langston - TD Cowen Brooks O'Neil - Lake Street Capital Markets David Larsen - BTIG Gene Mannheimer - Freedom Capital Markets Thomas Walsh - Barclays Operator Good day, everyone, and welcome to today's Astrana's Health First Quarter 2025 Earnings Call. seekingalpha.com - 2 months ago
Astrana Health, Inc. (ASTH) Q1 Earnings and Revenues Lag Estimates Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.31 per share a year ago. zacks.com - 2 months ago
Astrana Health, Inc. Reports First Quarter 2025 Results Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. prnewswire.com - 2 months ago
8. Profile Summary

Astrana Health, Inc. ASTH

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 1.15 B
Dividend Yield 0.00%
Description Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Contact 1668 S. Garfield Avenue, Alhambra, CA, 91801 https://www.astranahealth.com
IPO Date March 11, 2009
Employees 1900
Officers Mr. Brandon K. Sim M.S. President & Chief Executive Officer Ms. Rita Pew M.B.A. Chief People Officer Dr. Jeremy R. Jackson M.D. Chief Quality Officer Mr. Neil Ahuja President of Provider Solutions Mr. Chandan Basho M.B.A. Chief Financial Officer, Chief Operating Officer & Corporate Secretary Dr. Dinesh M. Kumar M.D. Chief Medical Officer Dr. Kenneth T. Sim M.D. Co-Founder & Executive Chairman Dr. Thomas S. Lam M.D., M.P.H. Co-Founder & Vice Chairman Dr. WaiChow Young M.D., M.P.H. Senior Vice President of Health Affairs Mr. Glenn W. Sobotka Chief Accounting Officer & Principal Accounting Officer